Sodium Bicarbonate Therapy for Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis

Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH 44195, USA.
American Journal of Kidney Diseases (Impact Factor: 5.9). 12/2008; 53(4):617-27. DOI: 10.1053/j.ajkd.2008.08.033
Source: PubMed


Optimal hydration measures to prevent contrast-induced nephropathy are controversial.
We conducted a systematic review and meta-analysis using the MEDLINE database (1966 to January 2008), EMBASE (January 2008), and abstracts from conference proceedings.
Adult patients undergoing contrast procedures.
Randomized controlled trials comparing intravenous hydration with sodium bicarbonate with hydration with intravenous normal saline for prevention of contrast-induced nephropathy.
Hydration with intravenous sodium bicarbonate with or without N-acetylcysteine versus hydration with normal saline with or without N-acetylcysteine.
Contrast-induced nephropathy, need for renal replacement therapy, and worsening of heart failure.
Twelve trials (1,854 participants) were included. Sodium bicarbonate significantly decreased the risk of contrast-induced nephropathy (12 trials, 1,652 patients; odds ratio [OR], 0.46; 95% confidence interval [CI], 0.26 to 0.82; I2 = 55.9%) without a significant difference in need for renal replacement therapy (9 trials, 1,215 patients; OR, 0.50; 95% CI, 0.16 to 1.53; I2 = 0%), in-hospital mortality (11 trials, 1,640 patients; OR, 0.51; 95% CI, 0.15 to 1.69), or congestive heart failure compared with controls. Similar results were seen for the risk of contrast-induced nephropathy when sodium bicarbonate was compared with normal saline alone (OR, 0.39; 95% CI, 0.20 to 0.77), but not when sodium bicarbonate/N-acetylcysteine combination was compared with N-acetylcysteine/normal saline combination (OR, 0.68; 95% CI, 0.34 to 1.37). A subgroup analysis limited to published trials showed similar results (OR, 0.26; 95% CI, 0.10 to 0.64; I2 = 63.3%), whereas unpublished studies showed a nonsignificant decrease (OR, 0.85; 95% CI, 0.46 to 1.57; I2 = 25.9%) in risk of contrast-induced nephropathy.
Publication bias and heterogeneity.
Hydration with sodium bicarbonate decreases the incidence of contrast-induced nephropathy in comparison to hydration with normal saline without a significant difference in need for renal replacement therapy and in-hospital mortality. Larger studies analyzing patient-centered outcomes are needed.

Download full-text


Available from: Sonal Singh,
  • Source
    • "CIN has been shown to be associated with an increased risk of prolonged hospital stay, increased risk of nosocomial complications, potential need for dialysis, increased health care costs and mortality [6,7]. Several studies showed effective interventions to decrease the risk for CIN [8,9]. Hydration of high-risk patients for CIN before contrast administration is a universally accepted appropriate and safe measure to prevent CIN [8]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Contrast-induced nephropathy (CIN) is a common cause of acute renal failure in hospital patients. To prevent CIN, identification and hydration of high-risk patients is important. Prevention of CIN by hydration of high-risk patients was one of the themes to be implemented in the Dutch Hospital Patient Safety Program. This study investigates to what extent high-risk patients are identified and hydrated before contrast administration. Hospital-related and admission-related factors associated with the hydration of high-risk patients are identified. The adherence to the guideline concerning identification and hydration of high-risk patients for CIN was evaluated retrospectively in 4297 patient records between November 2011 and December 2012. A multilevel logistic regression analysis was used to investigate the association between hospital-related and patient-related factors and hydration. The mean percentage patients with a known estimated Glomerular Filtration Rate before contrast administration was 96.4%. The mean percentage high-risk patients for CIN was 14.6%. The mean percentage high-risk patients hydrated before contrast administration was 68.5% and was constant over time. Differences between individual hospitals explained 19% of the variation in hydration. The estimated Glomerular Filtration Rate value and admission department were statistically significantly associated with the execution of hydration. The identification of high-risk patients was almost 100%, but the subsequent step in the prevention of CIN is less performed, as only two third of the high-risk patients were hydrated before contrast administration. Large variation between individual hospitals confirmed the difference in hospitals in correctly applying the guideline for preventing CIN.
    BMC Nephrology 01/2014; 15(1):2. DOI:10.1186/1471-2369-15-2 · 1.69 Impact Factor
  • Source
    • "Finally, diagnostic procedures such as computed tomography or magnetic resonance imaging involving iodine-containing or gadolinium-containing contrast agents, respectively, must be used with great caution in CKD patients of stage 4 and stage 5. Radiocontrast agents often cause radiocontrast nephropathy that is associated with an increase of overall mortality, especially in CKD patients. If not avoidable, preventive measures such as discontinuation of diuretics and prehydration are mandatory to minimize the risk of radiocontrast nephropathy [63]. The potential benefits of prophylactic N-acetylcysteine for the prevention of radiocontrast nephropathy remain under debate. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Renal co-morbidity is common in patients with rheumatic disease based on regular assessment of serum and urine parameters of renal function. When patients present with both arthritis and renal abnormalities the following questions have to be addressed. Is kidney disease a complication of rheumatic disease or its management, or are they both manifestations of a single systemic autoimmune disease? Is rheumatic disease a complication of kidney disease and its management? How do rheumatic disease and kidney disease affect each other even when they are unrelated? The present review provides an overview of how to address these questions in daily practice.
    Arthritis research & therapy 06/2011; 13(3):222. DOI:10.1186/ar3256 · 3.75 Impact Factor
  • Source
    • "La perfusion IV de bicarbonate de sodium, proposée par Merten et al., a fait l'objet par la suite de nombreuses publications, certaines ayant trouvé une supériorité par rapport au soluté salé isotonique et d'autres non [38]. La méta-analyse la plus récente est cependant en faveur de l'utilisation de bicarbonate de sodium [39]. Le volume d'administration optimal n'est pas non plus clairement établi. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Acute kidney injury is a common complication after contrast administration in radiology or cardiology. It increases morbidity and in-hospital but also long-term mortality. The pathophysiology is complex, there is an association of direct cellular toxicity of contrast agents and medullary ischemia secondary to alterations in intra-renal hemodynamics and to an increase in metabolic activity. Many risk factors have been identified and should be checked prior to injection, the most important being pre-existing renal failure which might be identified by calculating the estimated glomerular filtration rate with predictive equations such as Cockcroft–Gault or MDRD equations. When risk factors are present and contrast administration is really necessary, the only validated measure to reduce the risk of renal failure is still volume expansion. Other pharmacological interventions have interesting results, but a confirmation on a larger scale is necessary. The volume expansion is best performed intravenously by the isotonic saline or sodium bicarbonate.
    La Presse Médicale 07/2010; 39(7):807-814. DOI:10.1016/j.lpm.2010.02.046 · 1.08 Impact Factor
Show more